We are thankful to Dr. Danielle Carrick (Division of Cancer Control and Population Sciences, National Cancer Institute) for continued help, especially for initiating this study, providing us with the samples, and for helpful suggestions during data analysis. We sincerely thank all members of the CCR Sequencing Facility at the Frederick National Laboratory for Cancer Research for their help during sample preparation and sequencing, especially Brenda Ho for assistance in sample QC, Oksana German for library QC, Tatyana Smirnova for running the sequencers. We also would like to thank Tsai-wei Shen and Ashley Walton at Sequencing Facility Bioinformatics Group for helping with data analysis and RNA-seq pipeline implementation. We also thank CCBR and NCBR for assistance with RNaseq analysis pipeline and best practices development.

1. RNA quantity and quality assessment
<ol>
	<li>Select the FFPE samples according to predefined criteria and extract RNA using an appropriate method (e.g., FFPE-nuclei acid extraction kit, Table of Materials). 
	NOTE: There are several different methods available for FFPE-RNA extraction, including the newer microdissection methods that can work with very little tissue and extract good quality RNA12,13,14.</li>
	<li>Utmost care should be taken to preserve the integrity of RNA at all stages. This includes working with RNase free deionised water, using RNase free plasticware, and cleaning all instruments that come in contact with the FFPE blocks with RNase decontamination reagents.</li>
	<li>RNA should always be handled carefully and kept in ice unless otherwise specified to minimize degradation while handling.</li>
	<li>If enough material is available, extract RNA from more than one region in the FFPE block to generate biological replicates from as many samples as possible. For some of the samples with ample RNA yield, divide the extracted RNA into two to process as technical replicates.</li>
	<li>If possible, collect a small amount of sample separately after extraction for QC (i.e., a QC aliquot) to avoid repeated handling and freeze-thaw cycles of the sample that will likely lead to degradation of the RNA.</li>
	<li>Check the quality of the RNA (preferably from the QC aliquot) by running it on an RNA QC system (e.g., Agilent Bioanalyzer system using an RNA Nano chip, Table of Materials) according to the manufacturer&#8217;s instructions.</li>
	<li>Analyze the distribution of RNA fragments in the samples (e.g., using the Bioanalyzer 2100 Expert software) by calculating the DV200 and DV100 values as the percent of fragments larger than 200 nt (DV200) or 100 nt (DV100) in size.</li>
	<li>Among DV200 and DV100, identify the metric that has a larger spread of values for the given sample set, and pick that for grouping the samples according to their degree of intactness. 
	NOTE: For sample sets with more intact RNA molecules (i.e., high DV200 values, all or most with DV200 &#62; 40%), DV200 is likely to be a useful QC metric. However, for sample sets with more degraded transcripts (i.e., low DV200 values, all or most with DV200 &#60; 40%), DV100 is more likely to be useful.</li>
	<li>Based on the QC metrics, identify the samples that have DV100 &#60; 40%. Because this degree of degradation is highly likely to not generate useful sequencing data11, it is advisable to avoid processing such samples. If replacements for such samples are available, their quality should be checked to ideally only include samples with DV100 &#62; 50%.</li>
</ol>
2. Sequencing library preparation
<ol>
	<li>Based on the quality of the samples as assessed in section 1, identify an appropriate method for generating the sequencing libraries.
	<ol>
		<li>For sample sets with very low degradation and high DV200 values, use mRNA sequencing (i.e., capture of polyadenylated transcripts), targeted RNA sequencing (i.e., use of capture probes for specific genes of interest), RNA exome sequencing (i.e., use of capture probes to enrich for the coding transcriptome), or total RNA sequencing (i.e., use of random primers for reverse transcription to sequence the entire RNA population after removing ribosomal RNA from the samples). However, it is important to note that the fixation process may introduce bias in the extracted RNA. Thus, the capture approaches may not work well in all cases, even with high DV200 values.</li>
		<li>If the sample set includes samples with high degradation (DV200 &#60; 30%), use a total RNA library preparation method and not one that depends on the capture of specific regions of the transcripts, because those specific regions may be missing in degraded samples. The use of random primers for generation of cDNA leads to higher representation of usable RNA in the final library, and is, therefore, more suited for FFPE-RNA samples.</li>
		<li>For ribosomal RNA depletion for sample sets with high degradation, use RNaseH-based methods. These are methods where rRNA-specific DNA probes bind to rRNA, double-stranded molecules are digested by RNaseH, and leftover probes are cleaned up by DNase (e.g., NEBNext rRNA depletion kit, Table of Materials). These methods work better for degraded samples than some other methods8.</li>
	</ol>
	</li>
	<li>For generating sequencing libraries, use higher input amounts (if possible) for samples that have more degraded RNA (DV100 &#60; 60%). While samples with reasonably good quality RNA (DV100 &#62; 60%) may yield good sequence data even at lower input amounts (the lowest tested for this protocol with FFPE-RNA was ~20 ng), for more degraded RNA (DV100 &#60; 60%), it is better to start with higher input amounts (e.g., &#62;100 ng). 
	NOTE: If enough (e.g., &#62;500 ng) sample is available, it is advisable to save at least half of the sample for repeating the library preparation, if needed. For low input samples (e.g., &#60;100 ng), it is usually better to use the entire amount and generate a library of sufficient diversity.</li>
	<li>After selecting a suitable library preparation kit for generating total RNA seq libraries from samples with high degradation (e.g., NEBNext Ultra II RNA Library Prep Kit for Illumina, see Table of Materials), follow the manufacturer&#8217;s instructions to generate the libraries. 
	NOTE: During library preparation, it is important to skip the RNA fragmentation step for degraded samples and to ensure the use of random primers for first strand cDNA synthesis.</li>
	<li>For improving the efficiency and speed, especially for the low-input samples, use appropriate magnetic racks with strong fixed magnets for bead-based purification and size-selection steps (see Table of Materials).</li>
	<li>For PCR enrichment of adapter ligated DNA, adjust the number of amplification cycles based on the amount of input DNA to ensure maximum representation while avoiding unnecessary duplication of the library molecules. For low input FFPE-RNA samples (&#60;100 ng), we recommend 16&#8211;18 amplification cycles, while the high input samples (1,000 ng) usually generate enough library amounts in 12&#8211;14 rounds of amplification.</li>
	<li>Following PCR amplification and cleanup per the manufacturer&#8217;s instructions, assess the library quality by analyzing library concentration and molecule distribution on an appropriate platform (e.g., Agilent Bioanalyzer DNA Chip, see Table of Materials). For samples with primer peaks (~80 bp) or adapter-dimer peaks (~128 bp), repeat the cleanup to remove those peaks.</li>
	<li>Calculate the average library size for each library (e.g., using the Bioanalyzer 2100 Expert software).</li>
</ol>
3. Sequencing library QC
<ol>
	<li>Once it has been ascertained that the libraries are free of excess primer and adapter-dimers and have sufficient concentration for subsequent sequencing, quantitate further by qPCR. 
	NOTE: Owing to the sensitivity of cluster generation towards library concentration, accurate quantification is vital to prevent costly sequencing runs from underperformance or overloading. Quantitative real-time PCR (qPCR) methods are useful for improving cluster density on Illumina platforms without resulting in overclustering. The qPCR method is more precise and more sensitive than the methods based on qualitative and/or quantitative analysis of all library molecules (e.g., Agilent Bioanalyzer), because it measures the templates that have both adapter sequences on either end that will form clusters on the flowcell. Library size must, however, be known in advance as a size correction must be applied to all samples so that results can be compared against a standard curve. 
	CAUTION: Lab coats and gloves must always be worn when performing qPCR, and the procedure must be performed in a biosafety cabinet following the manufacturer&#8217;s instructions.
	<ol>
		<li>Set up a 96 well plate with three replicates for each sample for error prevention using a suitable kit (e.g., KAPA SYBR FAST qPCR Master Mix for Illumina libraries, a part of Library Quantification kit, see Table of Materials), along with the standards, a positive control (e.g, PhiX control, see Table of Materials), and a no template control (NTC). The NTC is qPCR mix without DNA library. The positive control can be any library with known concentration and fragment size.
		<ol>
			<li>Prepare a minimum of six dilutions of the standards following the vendor protocol.</li>
		</ol>
		</li>
		<li>After adding all the components (i.e., qPCR master mix, libraries, standards), cover the plate with sealing film and use a squeegee to ensure the film makes even and secure contact with the plate.</li>
		<li>Vortex and spin down the plate at 1,500 rpm for at least 1 min. Visually inspect the plate to make sure there are no air bubbles at the bottom of the wells.</li>
		<li>Set up the plate on the thermal cycler (e .g. CFX96 Touch System, see Table of Materials) using the manufacturer&#39;s recommended settings.</li>
		<li>Save the run folder where it can be accessed for data analysis.</li>
		<li>During data analysis, check that the slope is in the -3.1 to -3.6 range, efficiency from 90% to 110% and the R2 (coefficient of correlation obtained for the standard curve) no less than 0.98.</li>
	</ol>
	</li>
	<li>Pooling: Once the qPCR concentration of the sequencing ready libraries is obtained, pool equimolar amounts of each of the libraries, depending on the number of sequencing reads required per sample and the sequencing output of the instrument.</li>
	<li>QC of the pools: Quantitate the library pools again by qPCR following the same protocol as described in step 3.1.</li>
</ol>
4. Sequencing
<ol>
	<li>Depending on the run parameters, pull the sequencing reagent kits and thaw them following the user guide. Please check the Illumina website for the latest versions of all user guides for sequencing on Illumina instruments.</li>
	<li>Make sure the reagents are completely thawed and place the reagents tray at 4 &#176;C. The run should be started no later than 2 h after the reagents have been defrosted. Not doing that could affect quality of the run results.</li>
	<li>Invert the cartridge 5x to mix reagents and gently tap on the bench to reduce air bubbles.</li>
	<li>Set the unwrapped flow cell package aside at room temperature for 30 min.</li>
	<li>Unwrap the flow cell package and clean the glass surface of the flow cell with a lint-free alcohol wipe. Dry the glass with a low-lint laboratory tissue.</li>
	<li>Open the Illumina &#8220;Experiment Manager&#8221; application. Choose &#8220;Create Sample Sheet&#8221;, then choose the Sequencer and click &#8220;Next&#8221;.</li>
	<li>Create and upload the sample sheet based on Illumina sequencer criteria (e.g., Illumina Experiment Manager, software guide).</li>
	<li>At the prompts, scan in the reagent kit barcode and enter the run Set Up Parameters (e.g., for a single indexed PE 75 cycle run, enter 76-8-76).</li>
	<li>Denature and dilute the library pool based on the sequencer user guide recommendation (e.g., NextSeq 500 System guide from Illumina, see Table of Materials).</li>
	<li>Denature and dilute the control library PhiX (see Table of Materials) to the appropriate concentration (e.g., 1.8 pM for NextSeq).</li>
	<li>Mix sample library and PhiX control to result in a 1% PhiX control volume ratio.</li>
	<li>Load denatured and diluted sample into the reagent cartridge in the designated reservoir.</li>
	<li>Load the flowcell, buffer cartridge, and the reagent cartridge.</li>
	<li>Perform an automated check and review to ensure that the run parameters pass the system check.</li>
	<li>When the automated check is complete, select Start to begin the sequencing run.</li>
</ol>
5. Data analysis and quality assessment
NOTE: A typical RNA-seq data analysis workflow (Figure 1) includes preprocessing and QC, alignment to genome and post alignment QC, gene and transcript quantification, sample correlation analysis, differential analysis between different sample groups, treatment conditions, and gene set enrichment and pathway analysis.
The RNA-seq data may have quality issues that can affect the accuracy of gene profiling and lead to erroneous conclusions. Therefore, initial QC checks for sequencing quality, contamination, sequencing coverage bias, and other sources of artifacts are very important. Applying an RNA-Seq QC pipeline similar to the workflow described here is recommended to detect artifacts and apply filtering or correction before downstream analysis.
<ol>
	<li>Preprocessing 
	NOTE: This includes demultiplexing, assessment of sequence read quality, GC content, presence of sequencing adapters, overrepresented k-mers, and PCR duplicated reads. This information helps to detect sequencing errors, PCR artifacts, or contamination.
	<ol>
		<li>Demultiplex Illumina sequencing run using the Illumina software tool bcl2fastq2 to generate raw FASTQ files for each sample defined in the sample sheet. Allow one mismatch in the sample index barcodes to tolerate sequencing errors if there is no barcode collision.</li>
		<li>Run the FASTQC15 software tool to perform a quality check on raw FASTQ files to detect any poor quality or abnormalities in sequencing reads.</li>
		<li>For adapter and low-quality bases trimming, trim the sequencing adapters and low quality bases using Cutadapt16 or Trimmomatic17 software tools. Save the trimmed reads in the pair-end fastq files.</li>
		<li>Contamination screen
		<ol>
			<li>Run FASTQ_screen18 to detect possible cross contamination with other species.</li>
			<li>Run miniKraken of Kraken219 to identify the taxonomies of contaminating species.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Alignment to reference genome and post alignment QC
	<ol>
		<li>The trimmed reads can be aligned to a reference genome sequence (GRCh Build hg19 or hg38) using STAR aligner20. Apply the Gencode annotation GTF file to guide the spliced transcript alignment. It is recommended to run STAR 2-pass to increase sensitivity to novel splice junctions. In the second pass, all reads will be remapped using annotated gene and transcripts and novel junctions from the first pass.</li>
		<li>Perform post-alignment QC.
		<ol>
			<li>Run Picard&#8217;s21 MarkDuplicates to evaluate the library complexity by determining the amount of unique or nonduplicated reads in the samples.</li>
			<li>Run Picard&#8217;s CollectRnaSeqMetrics program to collect mapping percentages on coding, intronic, intergenic, UTR regions, and gene body coverage.</li>
			<li>Run RSeQC22 to determine the read pair inner distance, read distribution among CDS exons, 5&#8217;UTR, 3&#8217;UTR, intron, TSS_up_1kb, TSS_up_5kb, TSS_up_10kb, TES_down_1kb, TES_down_5kb, TES_down_10kb, read GC content, junction saturation, and library strand information.</li>
			<li>Run multi-QC23 to generate an aggregated report in HTML format.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Gene quantification and correction analysis
	<ol>
		<li>Run RSEM24 to get raw count as well as normalized read count on genes and transcripts. The read count measurement such as RPKM (reads per kilobase of exon model per million reads), FPKM (fragments per kilobase of exon model per million mapped reads), and TPM (transcripts per million) are the most often reported RNA-seq gene expression values. Genes expressed below a noised threshold (such as TPM &#60; 1 or raw count &#60;5) can be filtered.</li>
		<li>Perform transcript quantification to aggregate raw counts of mapped reads to each transcript sequences using programs such as HTSeq-count or featureCounts.</li>
		<li>Run Principal Components Analysis (PCA) using an R script to determine batch effects and assess a quality map of the given dataset25. Sample correlation analysis can be carried out using the Pearson correlation between different metrics.</li>
	</ol>
	</li>
	<li>Differential gene expression analysis
	<ol>
		<li>Perform gene differential analysis between sample conditions using the program edgeR26,27 and/or limma-Voom28 and use normalization methods including TPM, TMM, DESeq, or UpperQuartile.</li>
		<li>It is recommended to run at least two differential analysis software tools in order to call two set of DEGs lists for comparison and get the final DEGs to improve detection sensitivity and accuracy.</li>
	</ol>
	</li>
	<li>Gene set enrichment and pathway analysis
	<ol>
		<li>Perform Gene Set Enrichment Analysis (GSEA)29,30 based on ranking of transcripts according to a measurement of differentially expressed genes (DEGs) list to determine if the DEGs show statistically significant, concordant differences between biological conditions.</li>
		<li>Perform function analysis using resources such as Gene Ontology31, DAVID32,33, or other available software tools.</li>
	</ol>
	</li>
</ol>

<ol>
	<li>Carrick, D. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Robustness+of+Next+Generation+Sequencing+on+Older+Formalin-Fixed+Paraffin-Embedded+Tissue.">Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.</a> PLoS One. 10 (7), 0127353 (2015).</li><li>Hedegaard, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Next-generation+sequencing+of+RNA+and+DNA+isolated+from+paired+fresh-frozen+and+formalin-fixed+paraffin-embedded+samples+of+human+cancer+and+normal+tissue.">Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue.</a> PLoS One. 9 (5), 98187 (2014).</li><li>Zhang, P., Lehmann, B. D., Shyr, Y., Guo, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+Utilization+of+Formalin+Fixed-Paraffin-Embedded+Specimens+in+High+Throughput+Genomic+Studies.">The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies.</a> International Journal of Genomics. 2017, 1926304 (2017).</li><li>Srinivasan, M., Sedmak, D., Jewell, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+fixatives+and+tissue+processing+on+the+content+and+integrity+of+nucleic+acids.">Effect of fixatives and tissue processing on the content and integrity of nucleic acids.</a> American Journal of Pathology. 161 (6), 1961-1971 (2002).</li><li>von Ahlfen, S., Missel, A., Bendrat, K., Schlumpberger, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Determinants+of+RNA+quality+from+FFPE+samples.">Determinants of RNA quality from FFPE samples.</a> PLoS One. 2 (12), 1261 (2007).</li><li>Esteve-Codina, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Comparison+of+RNA-Seq+Results+from+Paired+Formalin-Fixed+Paraffin-Embedded+and+Fresh-Frozen+Glioblastoma+Tissue+Samples.">A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples.</a> PLoS One. 12 (1), 0170632 (2017).</li><li>Vukmirovic, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Identification+and+validation+of+differentially+expressed+transcripts+by+RNA-sequencing+of+formalin-fixed,+paraffin-embedded+(FFPE)+lung+tissue+from+patients+with+Idiopathic+Pulmonary+Fibrosis.">Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.</a> BMC Pulmonary Medicine. 17 (1), 15 (2017).</li><li>Adiconis, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Comparative+analysis+of+RNA+sequencing+methods+for+degraded+or+low-input+samples.">Comparative analysis of RNA sequencing methods for degraded or low-input samples.</a> Nature Methods. 10 (7), 623-629 (2013).</li><li>Sinicropi, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Whole+transcriptome+RNA-Seq+analysis+of+breast+cancer+recurrence+risk+using+formalin-fixed+paraffin-embedded+tumor+tissue.">Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissue.</a> PLoS One. 7 (7), 40092 (2012).</li><li>Altekruse, S. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=SEER+cancer+registry+biospecimen+research:+yesterday+and+tomorrow.">SEER cancer registry biospecimen research: yesterday and tomorrow.</a> Cancer Epidemiology, Biomarkers &amp; Prevention. 23 (12), 2681-2687 (2014).</li><li>Zhao, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Robustness+of+RNA+sequencing+on+older+formalin-fixed+paraffin-embedded+tissue+from+high-grade+ovarian+serous+adenocarcinomas.">Robustness of RNA sequencing on older formalin-fixed paraffin-embedded tissue from high-grade ovarian serous adenocarcinomas.</a> PLoS One. 14 (5), 0216050 (2019).</li><li>Amini, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=An+optimised+protocol+for+isolation+of+RNA+from+small+sections+of+laser-capture+microdissected+FFPE+tissue+amenable+for+next-generation+sequencing.">An optimised protocol for isolation of RNA from small sections of laser-capture microdissected FFPE tissue amenable for next-generation sequencing.</a> BMC Molecular Biology. 18 (1), 22 (2017).</li><li>Amini, P., Nassiri, S., Ettlin, J., Malbon, A., Markkanen, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Next-generation+RNA+sequencing+of+FFPE+subsections+reveals+highly+conserved+stromal+reprogramming+between+canine+and+human+mammary+carcinoma.">Next-generation RNA sequencing of FFPE subsections reveals highly conserved stromal reprogramming between canine and human mammary carcinoma.</a> Disease Models and Mechanisms. 12 (8), (2019).</li><li>Wimmer, I., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Systematic+evaluation+of+RNA+quality,+microarray+data+reliability+and+pathway+analysis+in+fresh,+fresh+frozen+and+formalin-fixed+paraffin-embedded+tissue+samples.">Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples.</a> Scientific Reports. 8 (1), 6351 (2018).</li><li>. Babraham Bioinformatics Available from: <a target="_blank" href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</a> (2019)</li><li>Martin, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cutadapt+removes+adapter+sequences+from+high-throughput+sequencing+reads.">Cutadapt removes adapter sequences from high-throughput sequencing reads.</a> EMBnet.journal. 17 (1), 10-12 (2011).</li><li>Bolger, A. M., Lohse, M., Usadel, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Trimmomatic:+a+flexible+trimmer+for+Illumina+sequence+data.">Trimmomatic: a flexible trimmer for Illumina sequence data.</a> Bioinformatics. 30 (15), 2114-2120 (2014).</li><li>. Babraham Bioinformatics Available from: <a target="_blank" href="https://www.bioinformatics.babraham.ac.uk/projects/fastq_screen/">https://www.bioinformatics.babraham.ac.uk/projects/fastq_screen/</a> (2019)</li><li>Wood, D. E., Salzberg, S. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Kraken:+ultrafast+metagenomic+sequence+classification+using+exact+alignments.">Kraken: ultrafast metagenomic sequence classification using exact alignments.</a> Genome Biology. 15 (3), 46 (2014).</li><li>Dobin, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=STAR:+ultrafast+universal+RNA-seq+aligner.">STAR: ultrafast universal RNA-seq aligner.</a> Bioinformatics. 29 (1), 15-21 (2013).</li><li>Wang, L., Wang, S., Li, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=RSeQC:+quality+control+of+RNA-seq+experiments.">RSeQC: quality control of RNA-seq experiments.</a> Bioinformatics. 28 (16), 2184-2185 (2012).</li><li>Ewels, P., Magnusson, M., Lundin, S., Kaller, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=MultiQC:+summarize+analysis+results+for+multiple+tools+and+samples+in+a+single+report.">MultiQC: summarize analysis results for multiple tools and samples in a single report.</a> Bioinformatics. 32 (19), 3047-3048 (2016).</li><li>Li, B., Dewey, C. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=RSEM:+accurate+transcript+quantification+from+RNA-Seq+data+with+or+without+a+reference+genome.">RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome.</a> BMC Bioinformatics. 12, 323 (2011).</li><li>Son, K., Yu, S., Shin, W., Han, K., Kang, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Simple+Guideline+to+Assess+the+Characteristics+of+RNA-Seq+Data.">A Simple Guideline to Assess the Characteristics of RNA-Seq Data.</a> BioMed Research International. 2018, 2906292 (2018).</li><li>McCarthy, D. J., Chen, Y., Smyth, G. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differential+expression+analysis+of+multifactor+RNA-Seq+experiments+with+respect+to+biological+variation.">Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation.</a> Nucleic Acids Research. 40 (10), 4288-4297 (2012).</li><li>Robinson, M. D., McCarthy, D. J., Smyth, G. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=edgeR:+a+Bioconductor+package+for+differential+expression+analysis+of+digital+gene+expression+data.">edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.</a> Bioinformatics. 26 (1), 139-140 (2010).</li><li>Ritchie, M. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=limma+powers+differential+expression+analyses+for+RNA-sequencing+and+microarray+studies.">limma powers differential expression analyses for RNA-sequencing and microarray studies.</a> Nucleic Acids Research. 43 (7), 47 (2015).</li><li>Subramanian, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gene+set+enrichment+analysis:+a+knowledge-based+approach+for+interpreting+genome-wide+expression+profiles.">Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.</a> Proceedings of the National Academy of Sciences of the United States of America U S A. 102 (43), 15545-15550 (2005).</li><li>Mootha, V. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=PGC-1alpha-responsive+genes+involved+in+oxidative+phosphorylation+are+coordinately+downregulated+in+human+diabetes.">PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.</a> Nature Genetics. 34 (3), 267-273 (2003).</li><li>Ashburner, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gene+ontology:+tool+for+the+unification+of+biology.+The+Gene+Ontology+Consortium.">Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.</a> Nature Genetics. 25 (1), 25-29 (2000).</li><li>Huang da, W., Sherman, B. T., Lempicki, R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Systematic+and+integrative+analysis+of+large+gene+lists+using+DAVID+bioinformatics+resources.">Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.</a> Nature Protocols. 4 (1), 44-57 (2009).</li><li>Huang da, W., Sherman, B. T., Lempicki, R. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bioinformatics+enrichment+tools:+paths+toward+the+comprehensive+functional+analysis+of+large+gene+lists.">Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists.</a> Nucleic Acids Research. 37 (1), 1-13 (2009).</li><li>Evaluating RNA Quality from FFPE Samples. Illumina Available from: <a target="_blank" href="https://www.illumina.com/content/dam/illumina-marketing/documents/products/technotes/evaluating-rna-quality-from-ffpe-samples-technical-note-470-2014-001.pdf">https://www.illumina.com/content/dam/illumina-marketing/documents/products/technotes/evaluating-rna-quality-from-ffpe-samples-technical-note-470-2014-001.pdf</a> (2016)</li></ol>

This work was funded by the National Cancer Institute (NCI), National Institutes of Health (NIH). Leidos Biomedical Research, Inc. is the operations and technical support contractor for the Frederick National Laboratory for Cancer Research which is fully funded by NIH. Several authors (YZ, MM, KT, YL, JS, BT) are affiliated with Leidos Biomedical Research, Inc., but all of the authors are fully funded by the National Cancer Institute including authors&#8217; salaries and research materials. Leidos Biomedical Research, Inc. did not provide salary for the authors (YZ, MM, KT, YL, JS, BT) or material for the study, nor did it have any role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.

The method described here outlines the main steps required to obtain good sequence data from FFPE-RNA samples. The main points to consider with this method are: (1) Ensure that the RNA is preserved as best as possible after extraction by minimizing the sample handling and freezing and thawing cycles. Separate QC aliquots are very helpful. (2) Use a QC metric that is best for the given sample set. RIN values and DV200 are often not useful for degraded samples, and DV100 may be the metric of choice to...

Use of next-generation sequencing approaches has enabled us to glean a wealth of information from various types of samples. However, old and poorly preserved samples remain unworkable for the commonly used methods of generating sequence data and often require modifications to well-established protocols. FFPE tissues represent such a sample type that has been widely utilized for clinical specimens1,2,3. While FFPE preservation maintains tissue morphology, the nucleic acids in FFPE tissues usually exhibit a wide range of damage and degradation, making it difficult to retrieve the genomic information that may lead to important insights about molecular mechanisms underlying various disorders.
Gene expression data generated by RNA sequencing is often instrumental in studying disease and resistance mechanisms and complements DNA mutation analysis. However, RNA is more susceptible to degradation, making it more challenging to generate accurate gene expression data from FFPE tissues. Furthermore, because the wide availability and affordability of sequencing is relatively recent, older specimens were often not stored in conditions required to preserve RNA integrity. Some of the issues for FFPE samples include degradation of RNA due to embedding in paraffin, chemical modification of RNA leading to fragmentation or refractoriness to enzymatic processes required for sequencing, and loss of the poly-A tails, limiting the applicability of oligo-dT as a primer for reverse transcriptase4. Another challenge is the handling/storage of FFPE samples under suboptimal conditions, which may lead to further degradation of labile molecules such as RNA in the tissues5. This is especially relevant for older samples that may have been collected at a time when gene expression analysis by RNA sequencing was not anticipated for the samples. All these lead to decreased quality and quantity of the extracted RNA available for generating useful sequence data. The low probability of success, combined with the high cost of sequencing, has dissuaded many researchers from trying to generate and analyze gene expression data from potentially useful FFPE samples. Some studies in recent years have demonstrated the usability of FFPE tissues for gene expression analysis2,6,7,8,9, albeit for fewer and/or more recent samples.
As a feasibility study, we used RNA extracted from FFPE tumor tissue specimens from three Residual Tissue Repositories from Surveillance, Epidemiology, and End Results (SEER) cancer registries for RNA sequencing and gene expression analysis10. Procured from clinical pathology labs, the FFPE tissues from high-grade ovarian serous adenocarcinomas were stored from 7&#8211;32 years under varying conditions before RNA extraction. Because in most cases these blocks had been stored in different sites for years without the expectation of any sensitive genetic analysis in the future, not much care had been taken to preserve the nucleic acids. Thus, most of the samples exhibited poor quality RNA, with a large proportion of samples contaminated with bacteria. Nevertheless, we were able to perform gene quantification, measure the uniformity and continuity of gene coverage, and perform the Pearson correlation analysis among biological replicates to measure reproducibility. Based on a set of key signature gene panel, we compared the samples in our study with The Cancer Genome Atlas (TCGA) data and confirmed that approximately 60% of the samples had comparable gene expression profiles11. Based on the correlation between various QC results and sample metadata, we identified key QC metrics that have good predictive value for identifying samples that are more likely to generate usable sequence data11.
Here we describe the methodology used for FFPE-RNA quality assessment, generation of sequencing libraries starting from extracted RNA samples, and bioinformatic analysis of the sequencing data.

<table>
	<tbody>
		<tr>
			<td>2100 Bioanalyzer</td>
			<td>Agilent</td>
			<td>G2939BA</td>
			<td></td>
		</tr>
		<tr>
			<td>Agilent DNA 7500 Kit</td>
			<td>Agilent</td>
			<td>5067-1506</td>
			<td></td>
		</tr>
		<tr>
			<td>Agilent High Sensitivity DNA Kit</td>
			<td>Agilent</td>
			<td>5067-4626</td>
			<td></td>
		</tr>
		<tr>
			<td>Agilent RNA 6000 Nano Kit</td>
			<td>Agilent</td>
			<td>5067-1511</td>
			<td></td>
		</tr>
		<tr>
			<td>AllPrep DNA/RNA FFPE Kit</td>
			<td>Qiagen</td>
			<td>80234</td>
			<td></td>
		</tr>
		<tr>
			<td>CFX96 Touch System</td>
			<td>Bio-Rad</td>
			<td>1855195</td>
			<td></td>
		</tr>
		<tr>
			<td>Library Quantification kit v2-Illumina</td>
			<td>KapaBiosystems</td>
			<td>KK4824</td>
			<td></td>
		</tr>
		<tr>
			<td>NEBNext Ultra II Directional RNA Library Prep Kit for Illumina</td>
			<td>New England Biolabs</td>
			<td>E7765S</td>
			<td>https://www.neb.com/protocols/2017/02/07/protocol-for-use-with-ffpe-rna-nebnext-rrna-depletion-kit</td>
		</tr>
		<tr>
			<td>NEBNext rRNA Depletion Kit (Human/Mouse/Rat)</td>
			<td>New England Biolabs</td>
			<td>E6310L</td>
			<td></td>
		</tr>
		<tr>
			<td>NextSeq 500 Sequencing System</td>
			<td>Illumina</td>
			<td>SY-415-1001</td>
			<td>NextSeq 500 System guide: https://support.illumina.com/content/dam/illumina-support/documents/documentation/system_documentation/nextseq/nextseq-500-system-guide-15046563-06.pdf</td>
		</tr>
		<tr>
			<td>NextSeq PhiX Control Kit</td>
			<td>Illumina</td>
			<td>FC-110-3002</td>
			<td></td>
		</tr>
		<tr>
			<td>NSQ 500/550 Hi Output KT v2.5 (150 CYS)</td>
			<td>Illumina</td>
			<td>20024907</td>
			<td></td>
		</tr>
		<tr>
			<td>10X Genomics Magnetic Separator</td>
			<td>10X Genomics</td>
			<td>120250</td>
			<td></td>
		</tr>
		<tr>
			<td>Rotator Multimixer</td>
			<td>VWR</td>
			<td>13916-822</td>
			<td></td>
		</tr>
		<tr>
			<td>C1000 Touch Thermal Cycler</td>
			<td>Bio-Rad</td>
			<td>1851197</td>
			<td></td>
		</tr>
		<tr>
			<td>Sequencing reagent kit</td>
			<td>Illumina</td>
			<td>20024907</td>
			<td></td>
		</tr>
		<tr>
			<td>Flow cell package</td>
			<td>Illumina</td>
			<td>20024907</td>
			<td></td>
		</tr>
		<tr>
			<td>Buffer cartridge and the reagent cartridge</td>
			<td>Illumina</td>
			<td>20024907</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium hydroxide solution (0.2N)</td>
			<td>Millipore Sigma</td>
			<td>SX0607D-6</td>
			<td></td>
		</tr>
		<tr>
			<td>TRIS-HCL Buffer 1.0M, pH 7.0</td>
			<td>Fisher Scientific</td>
			<td>50-151-871</td>
			<td></td>
		</tr>
	</tbody>
</table>

optimization for sequencing and analysis of degraded ffpe-rna samples

Gene expression analysis by RNA sequencing (RNA-seq) enables unique insights into clinical samples that can potentially lead to mechanistic understanding of the basis of various diseases as well as resistance and/or susceptibility mechanisms. However, FFPE tissues, which represent the most common method for preserving tissue morphology in clinical specimens, are not the best sources for gene expression profiling analysis. The RNA obtained from such samples is often degraded, fragmented, and chemically modified, which leads to suboptimal sequencing libraries. In turn, these generate poor quality sequence data that may not be reliable for gene expression analysis and mutation discovery. In order to make the most of FFPE samples and obtain the best possible data from low quality samples, it is important to take certain precautions while planning experimental design, preparing sequencing libraries, and during data analysis. This includes the use of appropriate metrics for precise sample quality control (QC), identifying the best methods for various steps during the sequencing library generation, and careful library QC. In addition, applying correct software tools and parameters for sequence data analysis is critical in order to identify artifacts in RNA-seq data, filter out contamination and low quality reads, assess uniformity of gene coverage, and measure the reproducibility of gene expression profiles among biological replicates. These steps can ensure high accuracy and reproducibility for profiling of very heterogeneous RNA samples. Here we describe the various steps for sample QC, library preparation and QC, sequencing, and data analysis that can help to increase the amount of useful data obtained from low quality RNA, such as that obtained from FFPE-RNA tissues.

The methodology described above was applied to 67 FFPE samples that had been stored under a variety of different conditions for 7&#8211;32 years (the median sample storage time was 17.5 years). The dataset and analysis results presented here were previously described and published in Zhao et al.11. On checking the sample quality as described earlier (i.e., example traces in Figure 2), DV100 was found to be more useful than DV200 because it is mor...

Watch this Scientific Journal Video about Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples at JoVE.com

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

This method describes the steps to improve the quality and quantity of sequence data that can be obtained from formalin-fixed paraffin-embedded (FFPE) RNA samples. We describe the methodology to more accurately assess the quality of FFPE-RNA samples, prepare sequencing libraries, and analyze the data from FFPE-RNA samples.

Gene expression analysis by RNA sequencing (RNA-seq) enables unique insights into clinical samples that can potentially lead to mechanistic understanding ...

optimization-for-sequencing-and-analysis-of-degraded-ffpe-rna-samples

Research

JoVE Journal

Genetics

11.8K Views.  Frederick National Laboratory for Cancer Research. This method describes the steps to improve the quality and quantity of sequence data that can be obtained from formalin-fixed paraffin-embedded (FFPE) RNA samples. We describe the methodology to more accurately assess the quality of FFPE-RNA samples, prepare sequencing libraries, and analyze the data from FFPE-RNA samples.

Video: Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

The Hodgkin Reed-Sternberg cells of classical Hodgkin lymphoma are sparsely distributed within a background of inflammatory lymphocytes and typically comprise less than 1% of the tumor mass. Material derived from bulk tumor contains tumor content at a concentration insufficient for characterization. Therefore, fluorescence activated cell sorting using eight antibodies, as well as side- and forward-scatter, is described here as a method of rapidly separating and concentrating with high purity thousands of HRS cells from the tumor for subsequent study. At the same time, because standard protocols for exome sequencing typically require 100-1,000 ng of input DNA, which is often too high, even with flow sorting, we also provide an optimized, low-input library construction protocol capable of producing high-quality data from as little as 10 ng of input DNA. This combination is capable of producing next-generation libraries suitable for hybridization capture of whole-exome baits or more focused targeted panels, as desired. Exome sequencing of the HRS cells, when compared against healthy intratumor T or B cells, can identify somatic alterations, including mutations, insertions and deletions, and copy number alterations. These findings elucidate the molecular biology of HRS cells and may reveal avenues for targeted drug treatments.

Here, we describe a combined flow cytometric cell sorting and low-input, next-generation library construction protocol designed to produce high-quality, whole-exome data from the Hodgkin Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (CHL).

The Hodgkin Reed-Sternberg cells of classical Hodgkin lymphoma are sparsely distributed within a background of inflammatory lymphocytes and typically ...

Detection of Copy Number Alterations Using Single Cell Sequencing

Detection of genomic changes at single cell resolution is important for characterizing genetic heterogeneity and evolution in normal tissues, cancers, and microbial populations. Traditional methods for assessing genetic heterogeneity have been limited by low resolution, low sensitivity, and/or low specificity. Single cell sequencing has emerged as a powerful tool for detecting genetic heterogeneity with high resolution, high sensitivity and, when appropriately analyzed, high specificity. Here we provide a protocol for the isolation, whole genome amplification, sequencing, and analysis of single cells. Our approach allows for the reliable identification of megabase-scale copy number variants in single cells. However, aspects of this protocol can also be applied to investigate other types of genetic alterations in single cells.

Single cell sequencing is an increasingly popular and accessible tool for addressing genomic changes at high resolution. We provide a protocol that uses single cell sequencing to identify copy number alterations in single cells.

Detection of genomic changes at single cell resolution is important for characterizing genetic heterogeneity and evolution in normal tissues, cancers, and ...

Optimization and Comparative Analysis of Plant Organellar DNA Enrichment Methods Suitable for Next-generation Sequencing

Plant organellar genomes contain large, repetitive elements that may undergo pairing or recombination to form complex structures and/or sub-genomic fragments. Organellar genomes also exist in admixtures within a given cell or tissue type (heteroplasmy), and an abundance of subtypes may change throughout development or when under stress (sub-stoichiometric shifting). Next-generation sequencing (NGS) technologies are required to obtain deeper understanding of organellar genome structure and function. Traditional sequencing studies use several methods to obtain organellar DNA: (1) If a large amount of starting tissue is used, it is homogenized and subjected to differential centrifugation and/or gradient purification. (2) If a smaller amount of tissue is used (i.e., if seeds, material, or space is limited), the same process is performed as in (1), followed by whole-genome amplification to obtain sufficient DNA. (3) Bioinformatics analysis can be used to sequence the total genomic DNA and to parse out organellar reads. All these methods have inherent challenges and tradeoffs. In (1), it may be difficult to obtain such a large amount of starting tissue; in (2), whole-genome amplification could introduce a sequencing bias; and in (3), homology between nuclear and organellar genomes could interfere with assembly and analysis. In plants with large nuclear genomes, it is advantageous to enrich for organellar DNA to reduce sequencing costs and sequence complexity for bioinformatics analyses. Here, we compare a traditional differential centrifugation method with a fourth method, an adapted CpG-methyl pulldown approach, to separate the total genomic DNA into nuclear and organellar fractions. Both methods yield sufficient DNA for NGS, DNA that is highly enriched for organellar sequences, albeit at different ratios in mitochondria and chloroplasts. We present the optimization of these methods for wheat leaf tissue and discuss major advantages and disadvantages of each approach in the context of sample input, protocol ease, and downstream application.

The comparison and optimization of two plant organellar DNA enrichment methods are presented: traditional differential centrifugation and fractionation of the total gDNA based on methylation status. We assess the resulting DNA quantity and quality, demonstrate performance in short-read next-generation sequencing, and discuss the potential for use in long-read single-molecule sequencing.

Plant organellar genomes contain large, repetitive elements that may undergo pairing or recombination to form complex structures and/or sub-genomic ...

Generation of Native Chromatin Immunoprecipitation Sequencing Libraries for Nucleosome Density Analysis

We present a modified native chromatin immunoprecipitation sequencing (ChIP-seq) experimental protocol compatible with a Gaussian mixture distribution based analysis methodology (nucleosome density ChIP-seq; ndChIP-seq) that enables the generation of combined measurements of micrococcal nuclease (MNase) accessibility with histone modification genome-wide. Nucleosome position and local density, and the posttranslational modification of their histone subunits, act in concert to regulate local transcription states. Combinatorial measurements of nucleosome accessibility with histone modification generated by ndChIP-seq allows for the simultaneous interrogation of these features. The ndChIP-seq methodology is applicable to small numbers of primary cells inaccessible to cross-linking based ChIP-seq protocols. Taken together, ndChIP-seq enables the measurement of histone modification in combination with local nucleosome density to obtain new insights into shared mechanisms that regulate RNA transcription within rare primary cell populations.

We present a modified native chromatin immunoprecipitation sequencing (ChIP-seq) methodology for the generation of sequence datasets suitable for a nucleosome density ChIP-seq analytical framework integrating micrococcal nuclease (MNase) accessibility with histone modification measurements.

We present a modified native chromatin immunoprecipitation sequencing (ChIP-seq) experimental protocol compatible with a Gaussian mixture distribution ...

Chromatin Immunoprecipitation (ChIP) Protocol for Low-abundance Embryonic Samples

Chromatin immunoprecipitation (ChIP) is a widely-used technique for mapping the localization of post-translationally modified histones, histone variants, transcription factors, or chromatin-modifying enzymes at a given locus or on a genome-wide scale. The combination of ChIP assays with next-generation sequencing (i.e., ChIP-Seq) is a powerful approach to globally uncover gene regulatory networks and to improve the functional annotation of genomes, especially of non-coding regulatory sequences. ChIP protocols normally require large amounts of cellular material, thus precluding the applicability of this method to investigating rare cell types or small tissue biopsies. In order to make the ChIP assay compatible with the amount of biological material that can typically be obtained in vivo during early vertebrate embryogenesis, we describe here a simplified ChIP protocol in which the number of steps required to complete the assay were reduced to minimize sample loss. This ChIP protocol has been successfully used to investigate different histone modifications in various embryonic chicken and adult mouse tissues using low to medium cell numbers (5 x 104 - 5 x 105 cells). Importantly, this protocol is compatible with ChIP-seq technology using standard library preparation methods, thus providing global epigenomic maps in highly relevant embryonic tissues.

Chromatin Immunoprecipitation ChIP Protocol for Low-abundance Embryonic Samples

Here, we describe a chromatin immunoprecipitation (ChIP) and ChIP-seq library preparation protocol to generate global epigenomic profiles from low-abundance chicken embryonic samples.

Chromatin immunoprecipitation (ChIP) is a widely-used technique for mapping the localization of post-translationally modified histones, histone variants, ...

Robust DNA Isolation and High-throughput Sequencing Library Construction for Herbarium Specimens

Herbaria are an invaluable source of plant material that can be used in a variety of biological studies. The use of herbarium specimens is associated with a number of challenges including sample preservation quality, degraded DNA, and destructive sampling of rare specimens. In order to more effectively use herbarium material in large sequencing projects, a dependable and scalable method of DNA isolation and library preparation is needed. This paper demonstrates a robust, beginning-to-end protocol for DNA isolation and high-throughput library construction from herbarium specimens that does not require modification for individual samples. This protocol is tailored for low quality dried plant material and takes advantage of existing methods by optimizing tissue grinding, modifying library size selection, and introducing an optional reamplification step for low yield libraries. Reamplification of low yield DNA libraries can rescue samples derived from irreplaceable and potentially valuable herbarium specimens, negating the need for additional destructive sampling and without introducing discernible sequencing bias for common phylogenetic applications. The protocol has been tested on hundreds of grass species, but is expected to be adaptable for use in other plant lineages after verification. This protocol can be limited by extremely degraded DNA, where fragments do not exist in the desired size range, and by secondary metabolites present in some plant material that inhibit clean DNA isolation. Overall, this protocol introduces a fast and comprehensive method that allows for DNA isolation and library preparation of 24 samples in less than 13 h, with only 8 h of active hands-on time with minimal modifications.

This article demonstrates a detailed protocol for DNA isolation and high-throughput sequencing library construction from herbarium material including rescue of exceptionally poor-quality DNA.

Herbaria are an invaluable source of plant material that can be used in a variety of biological studies. The use of herbarium specimens is associated with ...

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Conventional next-generation sequencing techniques (NGS) have allowed for immense genomic characterization for over a decade. Specifically, NGS has been used to analyze the spectrum of clonal mutations in malignancy. Though far more efficient than traditional Sanger methods, NGS struggles with identifying rare clonal and subclonal mutations due to its high error rate of ~0.5&#8211;2.0%. Thus, standard NGS has a limit of detection for mutations that are &#62;0.02 variant allele fraction (VAF). While the clinical significance for mutations this rare in patients without known disease remains unclear, patients treated for leukemia have significantly improved outcomes when residual disease is &#60;0.0001 by flow cytometry. In order to mitigate this artefactual background of NGS, numerous methods have been developed. Here we describe a method for Error-corrected DNA and RNA Sequencing (ECS), which involves tagging individual molecules with both a 16 bp random index for error-correction and an 8 bp patient-specific index for multiplexing. Our method can detect and track clonal mutations at variant allele fractions (VAFs) two orders of magnitude lower than the detection limit of NGS and as rare as 0.0001 VAF.

Next-generation sequencing (NGS) is a powerful tool for genomic characterization that is limited by the high error rate of the platform (~0.5&#8211;2.0%). We describe our methods of error-corrected sequencing that allow us to obviate the NGS error rate and detect mutations at variant allele fractions as rare as 0.0001.

Conventional next-generation sequencing techniques (NGS) have allowed for immense genomic characterization for over a decade. Specifically, NGS has been ...

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

The Full-Length Individual Proviral Sequencing (FLIPS) assay is an efficient and high-throughput method designed to amplify and sequence single, near full-length (intact and defective), HIV-1 proviruses. FLIPS allows determination of the genetic composition of integrated HIV-1 within a cell population. Through identifying defects within HIV-1 proviral sequences that arise during reverse transcription, such as large internal deletions, deleterious stop codons/hypermutation, frameshift mutations, and mutations/deletions in cis acting elements required for virion maturation, FLIPS can identify integrated proviruses incapable of replication. The FLIPS assay can be utilized to identify HIV-1 proviruses that lack these defects and are&#160;therefore potentially replication-competent. The FLIPS protocol involves: lysis of HIV-1 infected cells, nested PCR of near full-length HIV-1 proviruses (using primers targeted to the HIV-1 5&#39; and 3&#39; LTR), DNA purification and quantification, library preparation for Next-generation Sequencing (NGS), NGS, de novo assembly of proviral contigs, and a simple process of elimination for identifying replication-competent proviruses. FLIPS provides advantages over traditional methods designed to sequence integrated HIV-1 proviruses, such as single-proviral sequencing. FLIPS amplifies and sequences near full-length proviruses enabling replication competency to be determined, and also uses fewer amplification primers, preventing the consequences of primer mismatches. FLIPS is a useful tool for understanding the genetic landscape of integrated HIV-1 proviruses, especially within the latent reservoir, however, its utilization can extend to any application in which the genetic composition of integrated HIV-1 is required.

Full-length individual proviral sequencing (FLIPS) provides an efficient and high-throughput method for the amplification and sequencing of single, near full-length (intact and defective) HIV-1 proviruses and allows for determination of their potential replication-competency. FLIPS overcomes limitations of previous assays designed to sequence the latent HIV-1 reservoir.

The Full-Length Individual Proviral Sequencing (FLIPS) assay is an efficient and high-throughput method designed to amplify and sequence single, near ...

Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy

Chromosomal aneuploidy, one of the main causes leading to embryonic development arrest, implantation failure, or pregnancy loss, has been well documented in human embryos. Preimplantation genetic testing for aneuploidy (PGT-A) is a genetic test that significantly improves reproductive outcomes by detecting chromosomal abnormalities of embryos. Next-generation sequencing (NGS) provides a high-throughput and cost-effective approach for genetic analysis and has shown clinical applicability in PGT-A. Here, we present a rapid and low-cost semiconductor sequencing-based NGS method for screening of aneuploidy in embryos. The first step of the workflow is whole genome amplification (WGA) of the biopsied embryo specimen, followed by construction of sequencing library, and subsequent sequencing on the semiconductor sequencing system. Generally, for a PGT-A application, 24 samples can be loaded and sequenced on each chip generating 60&#8722;80 million reads at an average read length of 150 base pairs. The method provides a refined protocol for performing template amplification and enrichment of sequencing library, making the PGT-A detection reproducible, high-throughput, cost-efficient, and timesaving. The running time of this semiconductor sequencer is only 2&#8722;4 hours, shortening the turnaround time from receiving samples to issuing reports into 5 days. All these advantages make this assay an ideal method to detect chromosomal aneuploidies from embryos and thus, facilitate its wide application in PGT-A.

Here, we introduce a semiconductor sequencing method for preimplantation genetic testing for aneuploidy (PGT-A) with the advantages of short turnaround time, low cost, and high throughput.

Chromosomal aneuploidy, one of the main causes leading to embryonic development arrest, implantation failure, or pregnancy loss, has been well documented ...

Sequencing of mRNA from Whole Blood using Nanopore Sequencing

Sequencing in remote locations and resource-poor settings presents unique challenges. Nanopore sequencing can be successfully used under such conditions, and was deployed to West Africa during the recent Ebola virus epidemic, highlighting this possibility. In addition to its practical advantages (low cost, ease of equipment transport and use), this technology also provides fundamental advantages over second-generation sequencing approaches, particularly the very long read length, ability to directly sequence RNA, and real-time availability of data. Raw read accuracy is lower than with other sequencing platforms, which represents the main limitation of this technology; however, this can be partially mitigated by the high read depth generated. Here, we present a field-compatible protocol for sequencing of the mRNAs encoding for Niemann-Pick C1, which is the cellular receptor for ebolaviruses. This protocol encompasses extraction of RNA from animal blood samples, followed by RT-PCR for target enrichment, barcoding, library preparation, and the sequencing run itself, and can be easily adapted for use with other DNA or RNA targets.

Nanopore sequencing is a novel technology that allows cost-effective sequencing in remote locations and resource-poor settings. Here, we present a protocol for sequencing of mRNAs from whole blood that is compatible with such conditions.

Sequencing in remote locations and resource-poor settings presents unique challenges. Nanopore sequencing can be successfully used under such conditions, ...